Kazuko Hasegawa

10.0k total citations · 3 hit papers
128 papers, 4.1k citations indexed

About

Kazuko Hasegawa is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Kazuko Hasegawa has authored 128 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Neurology, 27 papers in Cellular and Molecular Neuroscience and 27 papers in Neurology. Recurrent topics in Kazuko Hasegawa's work include Parkinson's Disease Mechanisms and Treatments (73 papers), Neurological disorders and treatments (26 papers) and Neurological diseases and metabolism (23 papers). Kazuko Hasegawa is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (73 papers), Neurological disorders and treatments (26 papers) and Neurological diseases and metabolism (23 papers). Kazuko Hasegawa collaborates with scholars based in Japan, United States and United Kingdom. Kazuko Hasegawa's co-authors include Hisayuki Kowa, Fumiya Obata, Manabu Funayama, Shoji Tsuji, Miho Murata, Masaaki Saito, Saburo Yagishita, Shigeo Murayama, Ichiro Kanazawa and Masato Hasegawa and has published in prestigious journals such as Nature, The EMBO Journal and PLoS ONE.

In The Last Decade

Kazuko Hasegawa

120 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structures of α-synuclein filaments from multiple system atrophy

2020 510 citations Manuel Schweighauser, Yue‐De Yang et al. Nature profile →
Structures of α-synuclein filaments from human brains with Lewy pathology

2022 262 citations Yang Yang, Yue‐De Yang et al. Nature profile →
Widespread distribution of α-synuclein oligomers in LRRK2-related Parkinson’s disease

2025 14 citations Kazuko Hasegawa, Tatsushi Toda et al. Acta Neuropathologica profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazuko Hasegawa Japan	31	2.9k	1.2k	1.1k	1.1k	847	128	4.1k
Nicola Vanacore Italy	18	2.6k 0.9×	681 0.6×	1.4k 1.3×	1.1k 1.0×	802 0.9×	31	3.7k
Marijke Joosse Netherlands	14	1.8k 0.6×	1.2k 1.1×	1.1k 0.9×	1.4k 1.3×	667 0.8×	16	3.9k
Ebba Lohmann Türkiye	26	2.1k 0.7×	801 0.7×	1.2k 1.1×	826 0.7×	1.0k 1.2×	73	3.3k
Alessio Di Fonzo Italy	29	1.9k 0.6×	753 0.7×	814 0.7×	1.3k 1.1×	871 1.0×	116	3.3k
Mario Ezquerra Spain	28	1.7k 0.6×	1.1k 0.9×	782 0.7×	1.3k 1.2×	542 0.6×	85	3.0k
Paul T. Kotzbauer United States	31	2.1k 0.7×	1.8k 1.6×	1.6k 1.5×	2.1k 1.9×	1.1k 1.3×	52	5.2k
Manabu Funayama Japan	30	2.5k 0.8×	841 0.7×	1.1k 1.0×	1.3k 1.2×	1.0k 1.2×	76	3.8k
Guido J. Breedveld Netherlands	38	3.6k 1.2×	1.2k 1.1×	1.9k 1.7×	2.4k 2.2×	1.4k 1.6×	77	6.9k
Arianna Bellucci Italy	33	1.4k 0.5×	1.0k 0.9×	1.1k 1.0×	1.0k 0.9×	783 0.9×	72	3.2k
Piera Pasinelli United States	35	3.6k 1.2×	889 0.8×	1.3k 1.2×	2.3k 2.1×	947 1.1×	61	5.7k

Countries citing papers authored by Kazuko Hasegawa

Since Specialization

Citations

This map shows the geographic impact of Kazuko Hasegawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuko Hasegawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuko Hasegawa more than expected).

Fields of papers citing papers by Kazuko Hasegawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuko Hasegawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuko Hasegawa. The network helps show where Kazuko Hasegawa may publish in the future.

Co-authorship network of co-authors of Kazuko Hasegawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuko Hasegawa. A scholar is included among the top collaborators of Kazuko Hasegawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuko Hasegawa. Kazuko Hasegawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Uchino, A, Kazuko Hasegawa, Saburo Yagishita, et al.. (2025). Neuropathological examination of 12 cases of familial Parkinson’s disease with LRRK2 I2020T mutation including tau and TDP-43 pathology. Journal of Neurology. 272(7). 450–450. 2 indexed citations

Uchino, A, et al.. (2024). An autopsy case of MV 2K + C subtype of Creutzfeldt–Jakob disease. Neuropathology. 44(4). 304–313. 1 indexed citations

Takigawa, Hiroshi, Ritsuko Hanajima, Ikuko Aiba, et al.. (2024). Japanese longitudinal biomarker study in progressive supranuclear palsy and corticobasal degeneration: Clinical features of the first registered patients and short-term follow-up analysis. Clinical Parkinsonism & Related Disorders. 11. 100279–100279. 1 indexed citations

Yang, Yang, Yue‐De Yang, Manuel Schweighauser, et al.. (2022). Structures of α-synuclein filaments from human brains with Lewy pathology. Nature. 610(7933). 791–795. 262 indexed citations breakdown →

Schweighauser, Manuel, Yue‐De Yang, Airi Tarutani, et al.. (2020). Structures of α-synuclein filaments from multiple system atrophy. Nature. 585(7825). 464–469. 510 indexed citations breakdown →

Murata, Miho, et al.. (2019). Long-Term Efficacy for Parkinsonism and Safety of Zonisamide in Patients with Dementia with Lewy Bodies: A Phase III Trial (P4.1-011). Neurology. 92(15_supplement). 1 indexed citations

Ando, Rina, Hirotaka Iwaki, Masahiro Nagai, et al.. (2018). The Clinical Findings Useful for Driving Safety Advice for Parkinson's Disease Patients. Internal Medicine. 57(14). 1977–1982. 4 indexed citations

Murata, Miho, Masahito Mihara, Kazuko Hasegawa, et al.. (2016). Efficacy and safety of levodopa–carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson’s disease patients. npj Parkinson s Disease. 2(1). 16020–16020. 13 indexed citations

Nomoto, Masahiro, Yoshikuni Mizuno, Tomoyoshi Kondo, et al.. (2014). Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial. Journal of Neurology. 261(10). 1887–1893. 34 indexed citations

10.

Hasegawa, Kazuko, et al.. (2014). Psychology of patients with amyotrophic lateral sclerosis (ALS) compared with spinocerebellar degeneration, Parkinson's disease, and cerebrovascular disease. 44(1). 12–16. 1 indexed citations

11.

Asahina, Akihiko, Akira Ishiko, Ikuo Saito, et al.. (2012). Grover’s Disease Following Multiple Bilateral Blaschko Lines: A Rare Clinical Presentation with Genetic and Electron Microscopic Analyses. Dermatology. 225(2). 183–187. 10 indexed citations

12.

Tokuoka, Hirofumi, et al.. (2011). Biopterin levels in the cerebrospinal fluid of patients with PARK8 (I2020T). Journal of Neural Transmission. 118(6). 899–903. 3 indexed citations

13.

Hasegawa, Kazuko & Itaru Toyoshima. (2009). [Causative gene and its associated gene for Parkinson disease and dystonia].. PubMed. 61(4). 447–63. 2 indexed citations

14.

Mizuta, Ikuko, Tatsuhiko Tsunoda, Wataru Satake, et al.. (2008). Calbindin 1, fibroblast growth factor 20, and α-synuclein in sporadic Parkinson’s disease. Human Genetics. 124(1). 89–94. 47 indexed citations

15.

Sugiyama, Nobuhiro, Daimei Sasayama, Tomohiro Miyakawa, et al.. (2008). Prion disease causes less severe lesions in human hippocampus than other parts of brain. Psychiatry and Clinical Neurosciences. 62(3). 264–270. 11 indexed citations

16.

Hasegawa, Kazuko & Hisayuki Kowa. (1997). Autosomal Dominant Familial Parkinson Disease: Older Onset of Age, and Good Response to Levodopa Therapy. European Neurology. 38(1). 39–43. 40 indexed citations

17.

Abé, Hiroyuki, et al.. (1992). Argyrophilic glial intracytoplasmic inclusions in multiple system atrophy: immunocytochemical and ultrastructural study. Acta Neuropathologica. 84(3). 273–7. 53 indexed citations

18.

Hasegawa, Kazuko, Hisayuki Kowa, & Saburo Yagishita. (1992). Extrapyramidal system involvement in motor neuron disease. Journal of the Neurological Sciences. 108(2). 137–148. 22 indexed citations

19.

Nakano, Makoto, et al.. (1988). ACUTE UPPER GASTROINTESTINAL LESIONS DUE TO RANGER TRAINING WITH SPECIAL REFERENCE TO ACUTE GASTRIC ULCERS. Acta gastro-enterologica belgica. 30(5). 1 indexed citations

20.

Tsuhako, Mitsutomo, et al.. (1973). Studies on Preparations and Physical Properties of Multivalent Metal Condensed Phosphates VI. The Effect of Water Content on the Formation of Various Aluminum Phosphates. Chemistry Letters. 2(4). 367–370. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact